Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Cadisegliatin 800 mg QD

Cadisegliatin is an orally bioavailable small-molecule glucokinase activator; adjunctive therapy to insulin.

DRUG

Cadisegliatin 800 mg BID

Cadisegliatin is an orally bioavailable small-molecule glucokinase activator; adjunctive therapy to insulin.

DRUG

Placebo

Placebo (insulin alone)

Trial Locations (23)

10461

RECRUITING

Jacobi Medical Center, The Bronx

19104

RECRUITING

University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia

27514

RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

28557

RECRUITING

Lucas Research, Inc, Morehead City

30076

RECRUITING

Endocrine Research Solutions, Inc, Roswell

30114

RECRUITING

East Coast Institute for Research, LLC, Canton

30318

RECRUITING

Atlanta Diabetes Associates, Atlanta

31210

RECRUITING

The Jones Center Clinical Research, LLC, Macon

31904

RECRUITING

Centricity Research - Columbus, Columbus

33024

RECRUITING

ALL Medical Research, LLC, Cooper City

33413

RECRUITING

Metabolic Research Institute, Inc, West Palm Beach

50265

RECRUITING

Iowa Diabetes and Endocrinology Research Center, West Des Moines

75149

RECRUITING

Southern Endocrinology Associates PA, Mesquite

75230

RECRUITING

Velocity Clinical Research - Dallas, Dallas

78229

RECRUITING

Diabetes & Glandular Disease Clinic, P.A., San Antonio

78231

RECRUITING

Consano Clinical Research, Shavano Park

78731

RECRUITING

Texas Diabetes and Endocrinology, P.A, Austin

80113

RECRUITING

Denver Endocrinology Diabetes and Thyroid Center, Englewood

84405

WITHDRAWN

Advanced Research Institute - Ogden, Ogden

89436

RECRUITING

Vector Clinical Trials, Sparks

92025

RECRUITING

Advanced Metabolic Care & Research Institute, Inc. (AMCR), Escondido

92037

RECRUITING

Scripps Whittier Diabetes Institute, La Jolla

97504

RECRUITING

Velocity Clinical Research - Medford, Medford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

vTv Therapeutics

INDUSTRY